HealthEquity insider plans sale of common stock
HealthEquity, Inc. (HQY) filed a notice covering potential sales of its common stock by an affiliated holder through Morgan Stanley Smith Barney LLC Executive Financial Services.
Rhea-AI Filing Summary
HealthEquity, Inc. (HQY) filed a notice covering potential sales of its common stock by an affiliated holder through Morgan Stanley Smith Barney LLC Executive Financial Services. The filing lists 2,354 shares of common stock, linked to Restricted Stock Units acquired from the issuer on 07/01/2026, with an indicated value of $223,182.74 and NASDAQ trading. It also notes prior Rule 10b5-1 sales for Michael Fiore of 2,470 shares for $234,650.00 on 07/02/2026 and 3,142 shares for $298,490.00 on 05/29/2026 during the past three months.
Positive
- None.
Negative
- None.
Key Figures
Key Terms
Form 144 regulatory
Restricted Stock Units financial
Rule 10b5-1 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does HealthEquity (HQY) report in this Form 144 notice?
What recent Rule 10b5-1 sales for HQY stock by Michael Fiore are disclosed?
Which broker is involved with the HQY stock in this Form 144 filing?
On which exchange is the HQY stock referenced in this filing traded?
What time period of HQY stock sales is summarized in the past 3 months section?
AI-generated analysis. How Rhea-AI works. Not financial advice.